Abstract:OBJECTIVE:To measure the urokinase-type plasminogen activator (UPA) and its receptor (UPAR) in the plasma of patients with cerebral infarction and to study the effects of UPA and UPAR on cerebral infarction.METHODS:ELISA sandwich method was used to measure the plasma levels of UPA and UPAR in 89 patients with acute cerebral infarction, subdivided into mild, moderate and severe subgroups according to the modified Edinburgh-Scandinavia stroke scale (mESSS), and 30 patients with other disease and 30 healthy persons as controls.RESULTS:Within 2 days after the onset of cerebral infarction the UPA and UPAR levels were (1663.7 +/- 384.2) ng/L and (1 375.3 +/- 303.0) ng/L respectively, both significantly higher than those of the patients with other diseases [(1 033.0 +/- 122.7) ng/L and (978.3 +/- 120.0) ng/L respectively (P = 0.038 and P = 0.000)] and those of the normal control group [(1 005.0 +/- 128.9) ng/L and (904.7 +/- 158.6) ng/L respectively, both P = 0.000]. Two weeks after the onset of stroke, the plasma UPA level was (1 185.5 +/- 384.6) ng/L, not significantly different from those of the 2 control groups (both P > 0.05); while the plasma UPAR level in the cerebral infarction was (1 159.3 +/- 261.2) ng/L, significantly higher than those in the 2 control groups (P < 0.01). Within 2 days after the onset of infarction the plasma UPA and UPAR levels of the severe subgroup were (1 938.9 +/- 256.5) ng/L and (1 510.8 +/- 378.7) ng/L respectively, both significantly higher than those of the moderate subgroup [(1 593.7 +/- 204.8) ng/L and (1 296.6 +/- 151.2) ng/L respectively, both P < 0.01] and those of the mild subgroup [1 358.5 +/- 175.9] ng/L and (1 226.8 +/- 98.3) ng/L respectively, both P < 0.01], Two weeks after the onset of stroke,the plasma UPA and uPAR levels of the severe subgroup remained significantly higher than those of the mild subgroup [(1 152.6 +/- 170.3) ng/L vs (1 041.9 +/- 187.0) ng/L, (P < 0.05)] and [(1 186.4 +/- 158.3) ng/L vs (1 053.9 +/- 109.4) ng/L, (P < 0.01)]. In addition, the plasma UPA and UPAR levels of the patients who died from cerebral infarction at last were the highest among all the groups.CONCLUSION:The plasma levels pf UPA and UPAR increase in patients with cerebral infarction and may be related with the severity of disease. The UPA and UPAR genes may play an important role via proteolytic degradation of the extracellular matrix and basement membrane during the development of cerebral infarction.

[Changes of Plasma CD62p Levels in Patients with Acute Cerebral Infarction].

Change and Clinical Significance of Plasma CD62p, IL-6 in Patients with Cerebral Infarction

Study on the Changes of Plasma Levels of Brain natriureticpeptide(BNP) and C-Reactive Protein(CRP) in Patients with Acute Cerebral Infarction

Study on the Changes of Serum Levels of Interleukin-1β(IL-1β) and C-Reactive Protein(CRP) in Patients with Acute Cerebral Infarction

Analysis of correlation between oxidized low density lipoprotein and thrombus precursor protein with acute cerebral infarction

Study on Platelet Activation and Platelet Parameters in Patients with Cerebral Infarction

Dynamic changes and its clinical significance of ICAM-1, CD62p and CD63 in plasma of patients with cerebral infarction

The Research about the State of the Activated Blood Platelet of Cerebral Infarction Patients

Changes and significance of plasma placental growth factor levels in patients with cerebral infarction

[Expression of Urokinase-Type Plasminogen Activator and Its Receptor in Plasma of Patients with Cerebral Infarction].

Serum Concentrations of Adiponectin and Interlukin-10(IL-10) in Patients with Acute Cerebral Infarction

Change of serum soluble intercellular adhesion molecule and basic fibroblast growth factor in patients with acute cerebral infarction and its clinical significance]

A Study on the Relation of Plasma Fibrinogen and Activated Platelets in Patients with Ischemic Stroke

Level Changes of High Sensitivity C-reactive Protein, D-dimer and Fibrinogen in Patients with Cerebral Infarction

Clinical Analysis of Platelet Parameters in Patients with Acute Cerebral Infarction

[Serum Levels of Soluble Intercellular Adhesion Molecule-1 in Patients with Cerebral Infarct].

Study on Changes of Serum CXCL12 in Patients with Acute Cerebral Infarction and Its Clinical Significance

Quantitative Analysis of Platelet Function in Acute Cerebral Infarction

Study on expression of platelet membrane glycoproteins in cerebral infarction with carotid atherosclerosis

Changes of Circulating Endothelial Progenitor Cells and Their Clinical Significance in Patients with Acute Cerebral Infarction

Changes and Clinical Significance of Serum IL-6,sICAM-1 in Patients with Cerebral Infarcts